Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy
Capecitabine is a chemotherapeutic agent used in the treatment of metastatic colon cancer and metastatic breast cancer. It is metabolized into fluorouracil (5-FU) in the liver; hence, its mechanism of action is similar to that of 5-FU. Cardiac toxicity, although rarely seen, may be of concern in som...
Main Authors: | Uğur Nadir Karakulak, Elifcan Aladağ, Naresh Maharjan, Kenan Övünç |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2016-02-01
|
Series: | Türk Kardiyoloji Derneği Arşivi |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-36005 |
Similar Items
-
Capecitabine-induced-coronary-vasospasm leading to polymorphic ventricular tachycardia and cardiac arrest
by: Maciej Kabat, et al.
Published: (2024-02-01) -
Capecitabine-Induced Coronary Vasospasm
by: Danish Henry, et al.
Published: (2016-10-01) -
Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study
by: Jianjun Peng, et al.
Published: (2018-05-01) -
Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review
by: John Kouvaris, et al.
Published: (2008-08-01) -
Coronary Vasospasm After 5-Fluorouracil Therapy: Case Report
by: Ayşe ŞAHİN TUTAK, et al.
Published: (2016-08-01)